PhD student at Università di Bologna since 2019, carries on his research activity on the Medical Oncology field. Main research interests are neuroendocrine tumors, neuroendocrine and epithelial thoracic neoplasia and methods in clinical cancer research. His PhD project seeks to evaluate efficacy of immunotherapy and angiogenesis inhibition in small-cell lung cancer (SCLC). He
Education
Dr Lamberti got his degree in Medicine and Surgery in 2013 from l'Universita degli Studi "Federico II" of Naples and finished his training in Medical Oncology at Università di Bologna in 2019. Dr Lamberti spent his last year of training doing a clinical research fellowship at the Lowe Center for Thoracic Oncology del Dana-Farber Cancer Institute - Harvard Medical School Cancer Center of Boston, United States, where his research focused on predictive biomarker of immunotherapy response in thoracic malignancies.
Scientific production
Dr Lamberti authored over 25 publication in peer-review international scientific journals.
Scientific societies membership
Associazione Italiana Oncologia Medica (AIOM), European Society of Medical Oncology (ESMO), European Society of Neuroendocrine Tumors (ENETs), American Society of Medical Oncology (ASCO), International Association for the Study of Lung Cancer (IASLC), Associazione Italiana per i Tumori Neuroendocrini (It.a.NET), Methods in Clinical Cancer Research Alumni (MCCR Alumni), Society for Immunotherapy of Cancer (SITC).
Awards
2019: SITC 2019 Abstract travel Award
